Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (4630)	6/30/1998 10:12:00 AM
From: Henry Niman	Respond to of 6136

CNBC just report price drops in AGPH and VRTX due to Sustiva news.

To: Biomaven who wrote (4630)	6/30/1998 10:14:00 AM
From: Intel Trader	Respond to of 6136

Re: "Looks to me like today is the day to buy AGPH." I did at 30 11/16. it

To: Biomaven who wrote (4630)	6/30/1998 10:17:00 AM
From: Steve Fancy	Read Replies (1) \| Respond to of 6136

Yep, this continual buy on weakness strategy on this stock got me in a lot of trouble. The stock action as of late has been downright lousy...a sloooow but sure downtrend. The stock had not broken 31 this year until today I believe. Watch out if it goes below 30. If the Remune news on Thursday doesn't move the stock, could be trouble. AGPH seems to be going for broke...all these moves recently look to be panic driven moves...I suspect they know they had to do something. I am increasingly of the opinion that the only reason they're carrying on the AG3340 trials was to prevent the stock from tanking while they get their act together. The insider selling is making more sense. I know some here don't like these types of thoughts, but before I'm flamed, take a look at a two year chart. Hope this company doesn't take us all down along with it. sf